Results 11 to 20 of about 3,193,060 (260)

Primary vaginal adenocarcinoma of intestinal type or occult metastatic colon cancer: a diagnostic dilemma from a vaginal skin tag

International Journal of Women's Health, 2019
Anna Louise Russell,1 Ben Haagsma,2 Thumuluru Kavitha Madhuri3,4 1Department of Gynae-Oncology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK; 2Department of Histopathology, Royal Surrey County Hospital NHS Foundation Trust, Guildford,
Russell AL, Haagsma B, Madhuri TK
doaj   +1 more source

Vaginal metastasis from breast cancer: A case report

Open Life Sciences, 2023
Breast cancer is one of the most common malignancies in women. However, cases of vaginal metastases of breast cancer are rarely reported in China and abroad. The main clinical symptom of vaginal metastases of breast cancer is vaginal bleeding.
Yan Yunbo, Guo Tianjiao, Zhang Minmei, Cui Guozhong   +3 more
doaj   +1 more source

Trends in the Incidence of Vulvar and Vaginal Cancers With Different Histology by Race, Age, and Region in the United States (2001–2018)

International Journal of Public Health, 2022
Objectives: The race, age, and region-stratified incidence of vulvar (VUC) and vaginal (VAC) cancers with different histology were unclear.Methods: Data was retrieved from the United States Cancer Statistics database. Average annual percent change (AAPC)
Wei-Li Zhou, Yang-Yang Yue
doaj   +1 more source

Triapine Radiochemotherapy in Advanced Stage Cervical Cancer

Frontiers in Oncology, 2018
Clinical ribonucleotide reductase (RNR) inhibitors have reinvigorated enthusiasm for radiochemotherapy treatment of patients with regionally advanced stage cervical cancers.
Charles A. Kunos, S. Percy Ivy
doaj   +1 more source

Human Papilloma Virus: An Unraveled Enigma of Universal Burden of Malignancies

Pathogens, 2023
HPV, or Human Papilloma Virus, has been the primary causative agent of genital warts and cervical cancer worldwide. It is a sexually transmitted infection mainly affecting women of reproductive age group, also infecting men and high-risk group ...
Ishrat Khan, R Harshithkumar, Ashwini More, Anupam Mukherjee   +3 more
doaj   +1 more source

Insufficiency of timeliness and efficiency of diagnosis of malignant tumors of visual localization in the female reproductive system

Сибирский научный медицинский журнал, 2020
Reproductive system cancer is the most common female malignancy, accounting for 36.1 to 37.6 % of all gynecological cancers. The incidence rate of female reproductive system cancer continues to increase. Material and methods.
N. V. Voroshina, A. V. Vazhenin, Yu. A. Tyukov   +2 more
doaj   +1 more source

Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity substudy [PDF]

, 2023
Objective: The EMBRACE-vaginal morbidity substudy prospectively evaluated physician-assessed vaginal changes and patient-reported-outcomes (PRO) on vaginal and sexual functioning problems and distress in the first 2-years after image-guided radio(chemo ...
Nout, R. A., Sturdza, A.E., Jürgenliemk-Schulz, I M, Limbergen, E. van, Jürgenliemk-Schulz, I. M., Kirchheiner, K, Van Limbergen, E., J.C. Lindegaard, K. Tanderup, A.E. Sturdza, I.M. Jürgenliemk-Schulz, Tanderup, K, Sturdza, A E, Putter, H, Kirchheiner, K., I. Suvaal, C.L. Creutzberg, Nout, R.A., Jurgenliemk-Schulz, I.M., Kuile, M.M. ter, Nout, R A, Creutzberg, C L, ter Kuile, M. M., K. Kirchheiner, Creutzberg, C.L., Putter, H., Pötter, R., Pötter, R, Chargari, C., Van Limbergen, E, Lindegaard, J C, R.A. Nout, H. Putter, Chargari, C, Ter Kuile, M M, E. Van Limbergen, Creutzberg, C. L., C. Chargari, Lindegaard, J.C., R. Pötter, Suvaal, I, Suvaal, I., Lindegaard, J. C., Tanderup, K., M.M. ter Kuile, Sturdza, A. E.   +45 more
core   +2 more sources

The association between body mass index and vulvar and vaginal cancer incidence: findings from a large Norwegian cohort study. [PDF]

Cancer Causes Control
Background There is limited evidence of potential associations between body mass index (BMI) and risk of vulvar and vaginal cancer. We explored these associations in a large cohort of Norwegian women.
Aune D, Nordsletten M, Myklebust TÅ, Robsahm TE, Skålhegg BS, Mala T, Yaqub S, Saeed U.   +7 more
europepmc   +2 more sources

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention [PDF]

, 2009
With 2.5 million new HIV infections per year, effective preventive methods against HIV are urgently needed, especially in sub-Saharan Africa. MDP301 is an ongoing trial of the vaginal microbicide PRO 2000/5 being conducted by the Microbicides Development
Pool, Robert, Nunn, A., Pool, R, Nunn, A, Hayes Richard, Sheena McCormack, Rutterford, Clare, McCormack, S, Crook, A.M., Rutterford, C, Nunn, Andrew, McCormack, S., Crook, AM, Hayes, Richard, Richard Hayes, Hayes, R., Crook Angela M, Clare Rutterford, Rutteford, C., Angela M Crook, McCormack, Sheena, Pool, R., McCormack Sheena, Nunn Andrew, Crook, Angela M, Andrew Nunn, Rutterford Clare, Pool Robert, Robert Pool, Hayes, R   +29 more
core   +3 more sources

When an Unexpected Diagnosis Occurs: a Vaginal Premenopausal Sarcoma [PDF]

Revista Brasileira de Ginecologia e Obstetrícia, 2018
Vaginal cancer is a rare entity. The evidence on its management resides mostly in clinical cases or small case series. Of the histological types, the most frequent is the squamous cell carcinoma, followed by adenocarcinoma.
Pedro Marcos-Figueiredo, Diana de Sousa da Costa Moreira, Manuel Gonçalves Morim, Júlia Leite Pereira, Lurdes Silva Salgado   +4 more
doaj   +1 more source